Rock Springs Capital Management’s Pfizer PFE Stock Holding History

Rock Springs Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,962	Closed	-$407K	–	136
2019 Q4	$407K	Buy	+10,962	New	+$390K	0.01%	129
2016 Q4	–	Sell	-1,112,813	Closed	-$35.8M	–	138
2016 Q3	$35.8M	Hold	1,112,813	–	–	2.24%	9
2016 Q2	$37.2M	Buy	1,112,813 +18,445	+2%	+$589K	2.75%	5
2016 Q1	$30.8M	Buy	1,094,368 +66,718	+6%	+$1.91M	2.58%	7
2015 Q4	$31.5M	Buy	1,027,650 +226,610	+28%	+$7.13M	2.38%	8
2015 Q3	$23.9M	Hold	801,040	–	–	1.94%	10
2015 Q2	$25.5M	Hold	801,040	–	–	1.86%	12
2015 Q1	$26.4M	Buy	+801,040	New	+$25.5M	2.47%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Rock Springs Capital Management's PFE Position: Q1 2020 in Review

Rock Springs Capital Management sold out of Pfizer (PFE) in Q1 2020, closing a stake of 10,962 shares — an estimated $407K sold.

Rock Springs Capital Management first reported a position in PFE in Q1 2015 and held it in 8 quarters. The position peaked at $37.2M in Q2 2016. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

Rock Springs Capital Management reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
Rock Springs Capital Management sold 10,962 Pfizer shares in Q1 2020, an estimated $407K.
Rock Springs Capital Management first reported a position in Pfizer in Q1 2015 and held it in 8 quarters.
Rock Springs Capital Management's Pfizer position peaked at $37.2M in Q2 2016.
2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Rock Springs Capital Management's 13F filing for Q1 2020, filed 15 May 2020.